BAYLOR COLLEGE OF MEDICINE

- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Clinical Trials
722
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (603 trials with phase data)• Click on a phase to view related trials
Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD
- Conditions
- Obsessive Compulsive Disorder (OCD)Anxiety Disorder of Childhood or AdolescenceSocial Anxiety Disorder of ChildhoodGeneralized Anxiety Disorder (GAD)Separation Anxiety DisorderPanic DisorderPanic AttacksPanic Disorder (With or Without Agoraphobia)Phobia, Specific
- First Posted Date
- 2025-06-17
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 174
- Registration Number
- NCT07024758
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Effect of Platelet-Rich Plasma Versus Placebo in the Treatment of Central Centrifugal Cicatricial Alopecia
- Conditions
- Central Centrifugal Cicatricial Alopecia
- Interventions
- Biological: Platelet-Rich Plasma (PRP) InjectionsDrug: Saline
- First Posted Date
- 2025-05-31
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 56
- Registration Number
- NCT06998433
- Locations
- 🇺🇸
Jamail Specialty Care Center, Houston, Texas, United States
PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents
- Conditions
- Obesity and Diabetes Mellitus, Type 2Diabetes Prevention
- First Posted Date
- 2025-05-07
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT06959901
- Locations
- 🇺🇸
Children's Nutrition Research Center, Houston, Texas, United States
Intra-Arterial Magnesium Therapy After Mechanical Thrombectomy in Acute Ischemic Stroke
- First Posted Date
- 2025-05-04
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT06956521
Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
- Conditions
- Obesity and Type 2 Diabetes
- First Posted Date
- 2025-04-24
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT06943001
- Locations
- 🇺🇸
USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston, Texas, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 145
- Next
News
Breakthrough mRNA Vaccine Shows Promise Against Deadly Elephant Virus in First Real-World Test
Two young Asian elephants at Cincinnati Zoo successfully overcame Elephant Endotheliotropic Herpesvirus (EEHV) infection after receiving an experimental mRNA vaccine developed by Houston Zoo and Baylor College of Medicine.
ERA 2025 to Feature Pivotal Nephrology Trials Including CONFIDENCE, ACHIEVE, and VISIONARY Studies
The 62nd European Renal Association Congress in Vienna will present seven late-breaking clinical trials addressing chronic kidney disease, dialysis patients, and glomerular disease developments.
U.S. Measles Outbreak Intensifies: 600+ Cases Reported as HHS Secretary's Stance on Vaccines Draws Criticism
A severe measles outbreak has spread to 21 states with over 600 confirmed cases in 2025, primarily affecting unvaccinated individuals, with experts suspecting significant underreporting of actual case numbers.
Election-Related Stress Reaches Critical Levels Among Americans, APA Survey Reveals
A new American Psychological Association poll reveals 77% of Americans report stress about the nation's future, with 69% specifically worried about the upcoming presidential election.
FDA Launches Landmark Clinical Trial to Assess Kratom's Addiction Potential
Baylor College of Medicine researchers are initiating a $5.5 million FDA-funded clinical trial to evaluate kratom's abuse potential compared to oxycodone, with results expected in three years.
PanCAN Study Completes Enrollment of 8,800 Participants to Investigate Diabetes-Pancreatic Cancer Link
PanCAN's Early Detection Initiative has successfully enrolled over 8,800 participants to study the relationship between new-onset diabetes and early pancreatic cancer detection.
Groundbreaking CAR T-Cell Trial at Ben Taub Hospital Shows Promise in Multiple Myeloma Treatment
Harris Health's Ben Taub Hospital launches innovative cellular immunotherapy trial for multiple myeloma patients, demonstrating remarkable results with a single T-cell injection treatment.
Groundbreaking 18-Year Remission Achieved in Neuroblastoma Patient Following CAR T-Cell Therapy
A phase 1 clinical trial of GD2-targeted CAR T-cell therapy has achieved the longest reported remission in neuroblastoma treatment, with one patient remaining cancer-free for over 18 years.
Study Shows DAA Therapy Matches Interferon in Reducing Liver Cancer Risk for HCV Patients
• A large VA healthcare system study reveals that direct-acting antiviral (DAA) therapy significantly reduces hepatocellular carcinoma risk compared to no treatment in HCV patients with cirrhosis. • The research demonstrates comparable hepatocellular carcinoma risk reduction between DAA therapy and historical interferon treatments, with DAA achieving superior cure rates of over 95%. • Among study participants, 89.39% of DAA-treated patients achieved sustained virologic response, compared to 36.55% in the interferon-treated group, supporting DAA's favorable risk-benefit profile.
Precision Medicine and Value-Based Cancer Care: Navigating Implementation Challenges in Academic and Community Settings
Precision medicine adoption in oncology faces distinct challenges in academic and community settings, with issues ranging from workflow variations to bureaucratic constraints in implementing biomarker testing.